Pfizer Using TOMI Disinfection and Decontamination Products
A microcap company getting to put its name alongside a blue chip is generally beneficial for the upstart. That’s the case for decontamination and infection prevention specialist TOMI Environmental Solutions (OTCQX: TOMZ) on Wednesday as shareholders respond positively to further credence being lent to its disinfection and decontamination offerings.
TOMI said that is has completed installation of its iHP®
custom built-in system at the newly constructed research and development
facility of Pfizer (NYSE: PFE) in Chesterfield, Missouri. The biopharmaceutical stalwart broke ground
on the 295,000 square foot facility in June 2017. The facility is home to Pfizer’s
BioTherapeutics Pharmaceutical Sciences group, which works on R&D of
experimental new medicines.
TOMI installed several products from its SteraMist brand, a
hydrogen peroxide-based mist and fog underpinned by TOMI’s premier BIT™ (Binary
Ionization Technology®) platform, at the Chesterfield facility. Overall, TOMI installed SteraMist systems in
four clean room cGMP (current good manufacturing practice) suites and 20
ceiling mounted SteraMist applicators, which are tied in to dual generator
control cabinets that can run a single application or all at once as
necessary.
Pfizer will use the custom system daily as a means to
protect against the potential spread of any pathogens. Pfizer is well attuned to the quality of the
TOMI technology, already utilizing it in several of their facilities across the
U.S.
Shares of TOMZ popped up to a high of 12.8 cents this
morning, marking the highest level for the stock since April 20, 2018. With about 380,000 shares changing hands and
only minutes left in the trading day, the stock is posting its best volume day
since last April as well. The downside –
if it could be called that – is that the stock lost its early-day momentum,
trading flat at 12 cents as the closing bell approaches.
